Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more pr···【more】
Release date：2026-01-05Recommended：13
Adult patients with locally advanced or metastatic ROS1 positive non-small cell ···【more】
Release date：2026-01-05Recommended：0
Non small cell lung cancer with MET gene exon 14 mutation positive and unresecta···【more】
Release date：2026-01-05Recommended：8
iIndicated for the treatment of adult and pediatric patients 12 years and older ···【more】
Release date：2026-01-05Recommended：0
Deucravacitinib is suitable for treating plaque psoriasis.【more】
Release date：2026-01-05Recommended：17
Momelotinib is indicated for the treatment of intermediate or high-risk myelofib···【more】
Release date：2026-01-05Recommended：15
Used for relapsed/refractory mantle cell lymphoma and other B-cell malignancies.【more】
Release date：2026-01-05Recommended：5
Adult patients with moderate to severe rheumatoid arthritis (RA) who have insuff···【more】
Release date：2026-01-05Recommended：5
Daprodustat is indicated for the treatment of anemia due to chronic kidney disea···【more】
Release date：2026-01-05Recommended：9
The first-line treatment for metastatic non-small cell lung cancer with epiderma···【more】
Release date：2026-01-05Recommended：16
Used for the treatment of relapsed or refractory FLT3-ITD mutation positive acut···【more】
Release date：2026-01-05Recommended：9
Valcyte treatment for cytomegalovirus infection.【more】
Release date：2026-01-05Recommended：10
